Skip to main content
Fig. 2 | Journal of Pharmaceutical Health Care and Sciences

Fig. 2

From: Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database

Fig. 2

Comparison of the proportions of TDM implementation for each anti-MRSA agent before and after propensity score matching. Proportions of TDM implementation were compared by Chi-squared test. P value of ≤0.05 was considered statistically significant. TDM: therapeutic drug monitoring, VCM: vancomycin, TEIC: teicoplanin, ABK: arbekacin

Back to article page